secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001606498-25-000078
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos shareholders approve all proposals at 2025 annual meeting, including 2.25M share increase for LTIP
--------------------------------------------------------------------------------

- All five director nominees elected with 85.8% to 90.3% of votes cast; broker non-votes excluded.
- Deloitte & Touche ratified as auditor for 2025 with 94.7% of votes cast in favor.
- Say-on-pay advisory vote passed with 86.7% of votes cast for, 11.4% against.
- Amendment to 2021 Long Term Incentive Plan approved: 2,250,000 new shares added to reserve.
- 93.6% of outstanding shares represented at the meeting; high quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000078/0001606498-25-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000078/avns-20250424.htm
  HTML page:      https://secwatch.observer/filing/0001606498-25-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer